The race to develop therapies, obtain approval by regulators, and provide new treatments to patients has never been more competitive nor more important, yet the obstacles encountered along the path from discovery to approval threaten the successful launch of novel therapies.

Medidata Trial Design allows you to gain additional insights and evidence for the patient populations studied in your trial and accelerate time to market, lower risk, cut costs, and reduce patient burden.

This eBook explores real case studies and case studies of historical clinical trial data to shorten the time from discovery to approval of novel therapies, including:

• Identifying patients and defining target populations most likely to respond in a Phase III trial 
• Establishing endpoints that will best demonstrate therapeutic efficacy  
• Leveraging anonymized patient-level data to proactively mitigate the risk of serious adverse events in your trial